Loading...
XPARBLC
Market cap182mUSD
Dec 24, Last price  
24.05EUR
1D
-0.82%
1Q
17.89%
Jan 2017
1.26%
Name

Bastide le Confort Medical SA

Chart & Performance

D1W1MN
XPAR:BLC chart
P/E
P/S
0.33
EPS
Div Yield, %
0.93%
Shrs. gr., 5y
0.37%
Rev. gr., 5y
9.55%
Revenues
530m
+4.28%
94,841,00096,793,00099,952,000109,131,000123,573,000134,050,000152,131,000171,167,000191,850,000218,109,000289,050,000335,730,000382,706,000444,073,000468,300,000508,031,000529,755,000
Net income
-900k
L
5,889,0002,244,0002,855,0003,198,0003,517,0004,133,0005,115,0006,800,0007,184,0005,425,0007,158,0004,568,00011,600,00013,452,00013,681,00016,065,999-900,000
CFO
66m
-26.85%
11,731,000442,00016,529,00014,471,00017,215,00019,304,00018,202,00024,263,00031,582,00026,470,00050,408,00061,015,00039,609,00066,129,99946,758,00090,280,00066,038,000
Dividend
Jan 07, 20220.27 EUR/sh
Earnings
Mar 18, 2025

Profile

Bastide Le Confort Médical SA engages in the sale and rental of medical equipment in France. The company offers comfort and health products, such as lift chairs, bathroom and well-being products, pillows and cushions, seats, phones keys, measuring devices, technical aids, fitness products, blood pressure monitors, and pillboxes ; and incontinence products, including absorbent and support briefs, anatomical protections, protections for men and women, disposable mattress pads, PVC panties, and hygiene and body care products. It also provides medical materials comprising home support products wheel chairs, electric scooters, walkers, bed tables and rails, and transfer aids, air mattress, sick lifts, and standers; and medical equipment consisting of consumables, care and dressings, hygiene and disinfection products, outfits and briefcases, and other medical equipment, as well as home support services for elderly, senior, or disabled. It offers its products through approximately 130 stores, as well as through an online store. The company was founded in 1977 and is headquartered in Caissargues, France.
IPO date
May 15, 1997
Employees
3,375
Domiciled in
FR
Incorporated in
FR

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
529,755
4.28%
508,031
8.48%
468,300
5.46%
Cost of revenue
482,923
174,344
368,917
Unusual Expense (Income)
NOPBT
46,832
333,687
99,383
NOPBT Margin
8.84%
65.68%
21.22%
Operating Taxes
7,015
5,960
5,928
Tax Rate
14.98%
1.79%
5.96%
NOPAT
39,817
327,727
93,455
Net income
(900)
-105.60%
16,066
17.43%
13,681
1.70%
Dividends
(1,628)
(613)
(2,238)
Dividend yield
Proceeds from repurchase of equity
18
48
(226)
BB yield
Debt
Debt current
47,800
92,281
55,948
Long-term debt
412,527
394,882
363,285
Deferred revenue
59,770
66,320
Other long-term liabilities
5,480
4,569
4,672
Net debt
431,199
443,079
392,371
Cash flow
Cash from operating activities
66,038
90,280
46,758
CAPEX
(55,395)
(53,634)
(53,271)
Cash from investing activities
(43,654)
(76,269)
(104,736)
Cash from financing activities
(35,552)
7,533
39,809
FCF
51,723
343,676
59,104
Balance
Cash
23,616
36,706
22,133
Long term investments
5,512
7,378
4,729
Excess cash
2,640
18,682
3,447
Stockholders' equity
72,814
80,180
78,752
Invested Capital
474,092
501,371
507,121
ROIC
8.16%
64.99%
19.78%
ROCE
9.78%
63.64%
19.35%
EV
Common stock shares outstanding
7,460
7,938
7,373
Price
Market cap
EV
EBITDA
110,163
392,482
155,432
EV/EBITDA
Interest
27,369
16,593
12,779
Interest/NOPBT
58.44%
4.97%
12.86%